This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.
Janeen Skutnik
Advertisement
Janeen A. Skutnik is director of Quality & Regulatory Policy–Global Regulatory CMC at Pfizer.
Articles by Janeen Skutnik
Advertisement
Latest Updated Articles
- The Ideal Pharmacopeia
Published: November 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
